A Phase 1, Double Blind (Sponsor Open), Randomized, Placebo Controlled, Parallel Group, Oral Multiple Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF 03882845 In Healthy Volunteers.

Trial Profile

A Phase 1, Double Blind (Sponsor Open), Randomized, Placebo Controlled, Parallel Group, Oral Multiple Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF 03882845 In Healthy Volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 24 Dec 2009

At a glance

  • Drugs PF 3882845 (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 24 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Dec 2009 Actual patient number (10) added as reported by ClinicalTrials.gov.
    • 05 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top